Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €16.11 EUR
Change Today +0.262 / 1.65%
Volume 4.6K
NXU On Other Exchanges
Symbol
Exchange
Xetra
Xetra
As of 3:35 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

nexus ag (NXU) Snapshot

Open
€15.55
Previous Close
€15.84
Day High
€16.43
Day Low
€15.55
52 Week High
04/14/15 - €18.02
52 Week Low
12/16/14 - €10.13
Market Cap
253.4M
Average Volume 10 Days
12.5K
EPS TTM
€0.55
Shares Outstanding
15.7M
EX-Date
05/19/15
P/E TM
29.3x
Dividend
€0.13
Dividend Yield
0.74%
Current Stock Chart for NEXUS AG (NXU)

Related News

No related news articles were found.

nexus ag (NXU) Related Businessweek News

No Related Businessweek News Found

nexus ag (NXU) Details

Nexus AG develops and sells software and hardware solutions for hospitals, psychiatric institutions, and rehabilitation and social institutions worldwide. The company offers various information systems, such as NEXUS/HIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/HOME for senior citizen and nursing homes; NEXUS/REHA for rehabilitation institutions; NEXUS/HOSPIS, an administration information system for Swiss hospitals; and NEXUS/DIS, a diagnostic information system. It also offers NEXUS/GYNECOLOGY, an information system for obstetric institutes and gynecology; NEXUS/PATHOLOGY, an information system for pathology and cytology institutions; NEXUS/RADIOLOGY, a radiology information and image system for radiology wards and offices; NEXUS/INFORMATION STORE, a management information system for hospitals; and NEXUS/QM and NEXUS/SPM for quality management in the healthcare system. In addition, the company offers NEXUS/IS, an integration server for interface management of hospital information systems; NEXUS/IT, an outsourcing solution in healthcare; and Clinic WinData for medical diagnostics and equipment integration. Further, it provides ASS.TEC that offers process and HR consulting in an SAP environment; Asebis, a hospital solution for the Swiss market; PEGASOS, an archiving and process management in the healthcare system; E-med, a Web based hospital information system for French healthcare systems; NEXUS/MOBILE that provides device management, app monitoring, communication, and HIS integration; NEXUS/RIS/PACS, an integrated RIS/PACS solution; and NEXUS/MEDICATION for prescribing, checking, providing, and monitoring medicines. Additionally, the company provides NEXUS/PDMS, an intensive care solution; NEXUS/OBSTETRICS, a gynecology and obstetrics software; NEXUS/Cytology for cytology institutions; NEXUS/STERILIZATION that ensures gapless documentation of the sterile materials process. NEXUS AG is based in Villingen-Schwenningen, Germany.

662 Employees
Last Reported Date: 03/25/15

nexus ag (NXU) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nexus ag (NXU) Key Developments

Nexus AG Proposes Dividend for the Year 2014; Announces Consolidated Earnings Results for the Year 2014

Nexus AG announced that at the annual general meeting, the Supervisory Board and the Executive Board will propose to pay a dividend of 13 cents per share. The company announced consolidated earnings results for the year 2014. For the year, the company increased its sales by 9.4% to EUR 80,147,000 against EUR 73,263,000 a year ago. The operating result before taxes increased by 23.1% to EUR 8,243,000 against EUR 6,698,000 a year ago. As a result, NEXUS AG was able to continue its positive development of the prior years both with respect to sales and result stably in 2014. Group results before tax on income improved from EUR 6,698,000 in 2013 to EUR 8,243,000. The EBITDA reached EUR 15,044,000 following EUR 13,618,000 in the previous year. The EBITA improved by 10.9% from EUR 12,744,000 to EUR 14,138,000. The result per share increased by 14.6 % to 55 cents against 48 cents in 2013. Cash flow from on-going business operations increased by EUR 10,544,000 to EUR 11,594,000, up 10.0%.

Nexus AG to Report Fiscal Year 2014 Results on Mar 24, 2015

Nexus AG announced that they will report fiscal year 2014 results on Mar 24, 2015

Nexus Mulls Acquisition

Nexus AG (XTRA:NXU) is seeking acquisition. Nexus AG, said, “The increase in capital is used to finance the latest acquisitions. Executive Board also expects to get opportunities for further acquisitions selectively to increase market shares in Europe. The inflow of funds will be used for the further organic and inorganic growth of the group.”

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NXU:GR €16.11 EUR +0.262

NXU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $27.02 USD -0.23
Health Revenue Assurance Holdings Inc $0.0007 USD 0.00
McKesson Corp $229.23 USD +1.20
Siemens AG €100.47 EUR +1.51
View Industry Companies
 

Industry Analysis

NXU

Industry Average

Valuation NXU Industry Range
Price/Earnings 25.8x
Price/Sales 2.5x
Price/Book 2.8x
Price/Cash Flow 14.6x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEXUS AG, please visit www.nexus-ag.de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.